1-11 of 11
Peter Brossart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms

Kathrin Schönberg, Janna Rudolph, Maria Vonnahme, Sowmya Parampalli Yajnanarayana, Isabelle Cornez, Maryam Hejazi, Angela R. Manser, Markus Uhrberg, Walter Verbeek, Steffen Koschmieder, Tim H. Brümmendorf, Peter Brossart, Annkristin Heine, Dominik Wolf
Journal: Cancer Research
Cancer Res (2015) 75 (11): 2187–2199.
https://doi.org/10.1158/0008-5472.CAN-14-3198
Published: 31 May 2015
View articletitled, JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
Open the PDF for JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms in another window
Includes: Supplementary data
Journal Articles

BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells

Katharina M. Brauer, Daniela Werth, Karin von Schwarzenberg, Anita Bringmann, Lothar Kanz, Frank Grünebach, Peter Brossart
Journal: Cancer Research
Cancer Res (2007) 67 (11): 5489–5497.
https://doi.org/10.1158/0008-5472.CAN-07-0302
Published: 01 June 2007
View articletitled, BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells
Open the PDF for BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells in another window
Journal Articles

Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients

Jan Wierecky, Martin R. Müller, Stefan Wirths, Edith Halder-Oehler, Daniela Dörfel, Susanne M. Schmidt, Maik Häntschel, Wolfram Brugger, Stephen Schröder, Marius S. Horger, Lothar Kanz, Peter Brossart
Journal: Cancer Research
Cancer Res (2006) 66 (11): 5910–5918.
https://doi.org/10.1158/0008-5472.CAN-05-3905
Published: 01 June 2006
View articletitled, Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients
Open the PDF for Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients in another window
Includes: Supplementary data
Journal Articles

BCR-ABL Is Not an Immunodominant Antigen in Chronic Myelogenous Leukemia

Frank Grünebach, Valbona Mirakaj, Valdete Mirakaj, Martin R. Müller, Tim Brümmendorf, Peter Brossart
Journal: Cancer Research
Cancer Res (2006) 66 (11): 5892–5900.
https://doi.org/10.1158/0008-5472.CAN-05-2868
Published: 01 June 2006
View articletitled, BCR-ABL Is Not an Immunodominant Antigen in Chronic Myelogenous Leukemia
Open the PDF for BCR-ABL Is Not an Immunodominant Antigen in Chronic Myelogenous Leukemia in another window
Journal Articles

Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis

Susanne M. Schmidt, Kerstin Schag, Martin R. Müller, Toni Weinschenk, Silke Appel, Oliver Schoor, Markus M. Weck, Frank Grünebach, Lothar Kanz, Stefan Stevanovic, Hans-Georg Rammensee, Peter Brossart
Journal: Cancer Research
Cancer Res (2004) 64 (3): 1164–1170.
https://doi.org/10.1158/0008-5472.CAN-03-2538
Published: 10 February 2004
View articletitled, Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis
Open the PDF for Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis in another window
Journal Articles

Activated CD8+ T Lymphocytes Induce Differentiation of Monocytes to Dendritic Cells and Restore the Stimulatory Capacity of Interleukin 10-treated Antigen-presenting Cells

Stefan Wirths, Jeannette Reichert, Frank Grünebach, Peter Brossart
Journal: Cancer Research
Cancer Res (2002) 62 (17): 5065–5068.
Published: 01 September 2002
View articletitled, Activated CD8+ T Lymphocytes Induce Differentiation of Monocytes to Dendritic Cells and Restore the Stimulatory Capacity of Interleukin 10-treated Antigen-presenting Cells
Open the PDF for Activated CD8+ T Lymphocytes Induce Differentiation of Monocytes to Dendritic Cells and Restore the Stimulatory Capacity of Interleukin 10-treated Antigen-presenting Cells in another window
Journal Articles

The Epithelial Tumor Antigen MUC1 Is Expressed in Hematological Malignancies and Is Recognized by MUC1-specific Cytotoxic T-Lymphocytes

Peter Brossart, Anya Schneider, Patricia Dill, Theodora Schammann, Frank Grünebach, Stefan Wirths, Lothar Kanz, Hans-Jörg Bühring, Wolfram Brugger
Journal: Cancer Research
Cancer Res (2001) 61 (18): 6846–6850.
Published: 01 September 2001
View articletitled, The Epithelial Tumor Antigen MUC1 Is Expressed in Hematological Malignancies and Is Recognized by MUC1-specific Cytotoxic T-Lymphocytes
Open the PDF for The Epithelial Tumor Antigen MUC1 Is Expressed in Hematological Malignancies and Is Recognized by MUC1-specific Cytotoxic T-Lymphocytes in another window
Journal Articles

Tumor Necrosis Factor α and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells

Peter Brossart, Anke Zobywalski, Frank Grünebach, Lars Behnke, Gernot Stuhler, Volker L. Reichardt, Lothar Kanz, Wolfram Brugger
Journal: Cancer Research
Cancer Res (2000) 60 (16): 4485–4492.
Published: 01 August 2000
View articletitled, Tumor Necrosis Factor α and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells
Open the PDF for Tumor Necrosis Factor α and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells in another window
Journal Articles

Direct Identification of Major Histocompatibility Complex Class I-bound Tumor-associated Peptide Antigens of a Renal Carcinoma Cell Line by a Novel Mass Spectrometric Method

Thomas Flad, Bernhard Spengler, Hubert Kalbacher, Peter Brossart, Daniel Baier, Raimund Kaufmann, Peter Bold, Sabine Metzger, Martin Blüggel, Helmut E. Meyer, Bernd Kurz, Claudia A. Müller
Journal: Cancer Research
Cancer Res (1998) 58 (24): 5803–5811.
Published: 01 December 1998
View articletitled, Direct Identification of Major Histocompatibility Complex Class I-bound Tumor-associated Peptide Antigens of a Renal Carcinoma Cell Line by a Novel Mass Spectrometric Method
Open the PDF for Direct Identification of Major Histocompatibility Complex Class I-bound Tumor-associated Peptide Antigens of a Renal Carcinoma Cell Line by a Novel Mass Spectrometric Method in another window
Journal Articles

Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes

Peter Brossart, Gernot Stuhler, Thomas Flad, Stefan Stevanovic, Hans-Georg Rammensee, Lothar Kanz, Wolfram Brugger
Journal: Cancer Research
Cancer Res (1998) 58 (4): 732–736.
Published: 01 February 1998
View articletitled, Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes
Open the PDF for Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes in another window
Journal Articles

A Polymerase Chain Reaction-based Semiquantitative Assessment of Malignant Melanoma Cells in Peripheral Blood

Peter Brossart, Johann-W. Schmier, Stefan Krüger, Martina Willhauck, Carmen Scheibenbogen, Thomas Möhler, Ulrich Keilholz
Journal: Cancer Research
Cancer Res (1995) 55 (18): 4065–4068.
Published: 01 September 1995
View articletitled, A Polymerase Chain Reaction-based Semiquantitative Assessment of Malignant Melanoma Cells in Peripheral Blood
Open the PDF for A Polymerase Chain Reaction-based Semiquantitative Assessment of Malignant Melanoma Cells in Peripheral Blood in another window